Latisse® for Eyelashes
Some patients suffer from eyelash insufficiency, having short, thin eyelashes, (hypotrichosis). They may be candidates for treatment with Latisse®. Latisse® (bimatoprost ophthalmic solution 0.03%) is an FDA-approved treatment for patients with eyelash insufficiency (hypotrichosis), helping to grow longer, thicker eyelashes. It requires a prescription and a discussion of the possible risks and side effects. The medication in Latisse® has been used for years to treat glaucoma. Ophthalmologists are perhaps the physicians most familiar with this medication and its risk profile.